SCHEMBL20244284

SCHEMBL20244284

C=C(/C=C/c1ccc(C#N)cc1)c1ccc(OC)c(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 5/20 0.55
▸ TNFRSF1A P19438 3/20 0.53
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ PDE4A P27815 2/20 0.47
▸ PDE4B Q07343 2/20 0.47
▸ PDE4C Q08493 2/20 0.47
▸ PDE4D Q08499 2/20 0.47
▸ ABCB1 P08183 1/20 0.45
▸ P4HB P07237 3/20 0.45
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10582957 0.84 ABCG2 (0.79) ABCG2TNFRSF1AMEN1KMT2ALMNA
SCHEMBL10582964 0.84 ABCG2 (0.79) ABCG2TNFRSF1AMEN1KMT2ALMNA
SCHEMBL13567360 0.78 PDE4A (0.64) ABCG2TNFRSF1AMEN1KMT2APDE4A
SCHEMBL4995196 0.76 TUBB4A (0.58) ABCG2PDE4BABCB1SMN1; SMN2
SCHEMBL4995193 0.76 TUBB4A (0.58) ABCG2PDE4BABCB1SMN1; SMN2
SCHEMBL20244293 0.75 MAPT (0.69) TNFRSF1AKMT2ALMNAMAPTATM
SCHEMBL15807424 0.74 ABCG2 (0.63) ABCG2TNFRSF1AMEN1KMT2ALMNA
SCHEMBL14306013 0.74 ABCG2 (0.79) ABCG2TNFRSF1ALMNAMAPTABCB1
SCHEMBL23395752 0.72 HDAC2 (0.51) LMNAMAPTP4HBKDM4EALDH1A1
SCHEMBL25221520 0.72 P4HB (0.73) ABCG2TNFRSF1AMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3333153-A1 NUCLEAR RECEPTOR MODULATORS AND THEIR USE FOR THE TREATMENT AND PREVENTION OF CANCER The U.S.A. as represented by the Secretary, Department of Health and Human Services (US) 2018-06-13 — — EP disclosed
Send feedback